Treating sickle cell anemia

Affiliations

¹ Cellular and Molecular Therapeutics Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD 20892, USA. johntis@nhlbi.nih.gov eaton@nih.gov sweelay.thein@nih.gov.
² Sickle Cell Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD 20892, USA. johntis@nhlbi.nih.gov eaton@nih.gov sweelay.thein@nih.gov.
³ Laboratory of Chemical Physics, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA. johntis@nhlbi.nih.gov eaton@nih.gov sweelay.thein@nih.gov.

John F Tisdale et al. Science. 2020.

. 2020 Mar 13;367(6483):1198-1199.

doi: 10.1126/science.aba3827.

¹ Cellular and Molecular Therapeutics Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD 20892, USA. johntis@nhlbi.nih.gov eaton@nih.gov sweelay.thein@nih.gov.
² Sickle Cell Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD 20892, USA. johntis@nhlbi.nih.gov eaton@nih.gov sweelay.thein@nih.gov.
³ Laboratory of Chemical Physics, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA. johntis@nhlbi.nih.gov eaton@nih.gov sweelay.thein@nih.gov.

No abstract available

References